Trouver Propionate De Testostérone, Testostérone 17-Propionate, 17- (1-oxopropoxy) - (17-bêta) -Androst-4-En-3-on dans le répertoire Industry, Reliable Fabricant / Fournisseur / Factory de Chine

Panier (0)
Accueil > Liste de Produits > Intermédiaire pharmaceutique > CAS: 137986-29-9 Sarms de produit de soins de santé de haute qualité (SR9009)

CAS: 137986-29-9 Sarms de produit de soins de santé de haute qualité (SR9009)

Informations de base

Modèle:  CAS NO

Description du produit

N ° de Modèle: N ° CAS: 71447-49-9 Nom: Sr9009 Formule moléculaire: C20h24cln3o4s Solubilité: DMSO Spécifications: GMP, ISO Code SH: 3001200010 Pureté: 99% N ° CAS: 1379686-30-2 Poids moléculaire: 437.94 Marque: gongchuang Origine: Hubei Description du produit \ n \ n1 & period; Date de base \ nNom: SR9009 \ nCAS No & period ;: 1379686-30-2 \ nFormule moléculaire: C20H24ClN3O4S \ n \ n2 & period; Détails de SR9009 \ nSuperlist Nom: SR9009 Formule \ nMolecular: C20H24ClN3O4S \ nCAS No & period ;: 1379686-30-2 \ nPurity: 99 & percnt; \ nSynonyms: Ethyl-3- & lpar; & lpar; & 4-chlorobenzyl & quot; & lpar; & lpar; 5 -nitrothiophène-2-yl & md; méthyl & rpar; amino & rpar; méthyl & rpar; pyrrolidine-1-carboxylate \ nMolecular poids: 437 & period; 94 \ nAppearance: Poudre blanche \ nSolubilité: DMSO \ nPort: SH \ nApplication: SR9009 augmentation exercice endurance et perte poids & period; \ ndétails

Systematic (IUPAC) name ethyl-3-(((4-chlorobenzyl)((5-nitrothiophen-2-yl)methyl)amino)methyl)pyrrolidine-1-carboxylate
CAS number 1379686-30-2
Formula C20H24ClN3O4S
Appearance white powder
Quality Standard 98% by HPLC
Application New generation supplements for gaining mass and cutting edges
stock bulk in stock
\ n \ n \ nSR9009 est un médicament de recherche qui a été développé par le professeur Thomas Burris du Scripps Research Institute comme agoniste de Rev-ErbA & period; e & period ;, augmente la répression constitutive des gènes régulés par Rev-ErbA & rpar; avec une concentration inhibitrice demi-maximale & lpar; IC50 & rpar; &équivaut à; 670 nM pour Rev-ErbAα et IC50 & égaux; 800 nM pour Rev-ErbAβ & period; \ nActivation de Rev-erb-α par chez la souris SR9009 augmente la capacité d'exercice chez les souris en augmentant les mitochondries dans le muscle squelettique & période; \ n \ n \ nNotre avantage \ n \ n

We have experience in exporting steroids, as you know, EU places much emphasis on them, and you must find
a experienced partner who will assure you;
2. Quality: Our company is a professional leading factory in China in pharmaceutical area, We had stable
customers and exported to Germany, Spain, UK, USA, Australia, Middle East, and any other countries.
We can provide good references about our company. As for the quality of the products,
we 're sure they can satisfy you well enough;
3. Package: Professional packing with professional materials
4. Delivery We have products in stock, and we will deliver them soon when your PO arrived.
Meanwhile we will give you the tracking number in order to make you know the exact location
of the products. We will keep track of the product until they arrive you; We choose the
best courier service for you, and with the delivery around 3-5 working days.
5. Service Best Service with after-sales service and consultation,we have an excellent customer service driven approach to our business,
unlike most sites we are consistently available via sales hotline, email, skype or MSN and always respond to emails within 30 mins
\ n \ n \ autres produits connexes \ n
Name CAS NO. Usage
AICAR 2627-69-2 acts by entering nucleoside pools, significantly increasing levels of adenosine
during periods of ATP breakdown
MK2866 841205-47-8 medical prescription for prevention of cachexia, atrophy, and sarcopenia and
for Hormone or Testoserone Replacement Therapy.
MK-677 15972-10-0 A growth hormone secretagogue, treatment of obesity, a promising therapy
for the treatment of frailty in the elderly
LGD-4033 1165910-22-4 pharmacological profile similar to that of enobosarm, Ostarine,MK-2866
GW1516 317318-70-0 For obesity, diabetes, dyslipidemia and cardiovascular disease
Andarine(S4) 401900-40-0 partial agonist, intended mainly for treatment of benign prostatic hypertrophy
SR9009 1379686-30-2 under development at The Scripps Research Institute (TSRI),
increases the level of metabolic activity in skeletal muscles of mice
RAD140 1182367-47-0 New generation for gaining mass and cutting edges
YK11 431579-34-9 YK11: a SARM and myostatin inhibitor in one
\ n

Groupes de Produits : Intermédiaire pharmaceutique

Envoyer à ce fournisseur
  • *Sujet:
  • pour:

  • *Messages:
    Votre message doit comporter de 20 à 8000 caractères